VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

68 hedge funds and large institutions have $65.1M invested in Viracta Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 12 closing their positions.

Holders
68
Holders Change
+1
Holders Change %
+1.49%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
15
Reduced
22
Closed
12
Calls
$143K
Puts
$341K
Net Calls
-$198K
Net Calls Change
-$22K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$2.1M
2
BI
2
BVF Inc
California
$12.6M
3
BlackRock
3
BlackRock
New York
$8.65M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$582K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$422K

Top Sellers

1
ASP
1
Adams Street Partners
Illinois
$0
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$296K
3
OM
3
Opaleye Management
Massachusetts
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$63K
5
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RM
1
RP Management
New York
$13.5M 3,700 – –
BI
2
BVF Inc
California
$12.6M 3,438,944 +344,770 +11%
BlackRock
3
BlackRock
New York
$8.65M 2,368,918 +283,870 +14%
Citadel Advisors
4
Citadel Advisors
Florida
$5.61M 1,535,829 -2,533 -0.2%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.31M 1,454,326 +9,711 +0.7%
SB
6
Samsara BioCapital
California
$2.6M 711,039 – –
Morgan Stanley
7
Morgan Stanley
New York
$2.1M 576,077 +544,576 +1,729%
State Street
8
State Street
Massachusetts
$2.1M 575,089 -2,463 -0.4%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.68M 461,227 -20,074 -4%
Northern Trust
10
Northern Trust
Illinois
$1.07M 293,492 -8,604 -3%
ACM
11
Aisling Capital Management
New York
$1.05M 288,571 – –
GGHC
12
Gilder Gagnon Howe & Co
New York
$783K 214,566 +63,216 +42%
Goldman Sachs
13
Goldman Sachs
New York
$702K 192,251 +21,057 +12%
Two Sigma Investments
14
Two Sigma Investments
New York
$582K 159,331 +159,331 New
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$502K 137,607 -44,712 -25%
Nuveen Asset Management
16
Nuveen Asset Management
Illinois
$479K 141,929 -9,529 -6%
Renaissance Technologies
17
Renaissance Technologies
New York
$422K 115,700 +115,700 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$402K 110,013 +2,075 +2%
JRP
19
Jasper Ridge Partners
California
$339K 92,939 – –
AA
20
AlphaCentric Advisors
Puerto Rico
$329K 90,000 -2,402 -3%
Charles Schwab
21
Charles Schwab
California
$315K 86,060 – –
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$296K 81,136 -987,676 -92%
Wells Fargo
23
Wells Fargo
California
$277K 75,859 +65,457 +629%
Allspring Global Investments
24
Allspring Global Investments
North Carolina
$266K 73,011 +73,011 New
HLA
25
Hamilton Lane Advisors
Pennsylvania
$261K 71,491 – –
1
2 3 4